[Results of specific immunotherapy with Allergovit in patients with pollen allergy].
The immunotherapy among patients with pollen allergy was performed by individuals composed Allergovit. The effects of this treatment was compared to patients with pollenosis who don't have desensitization because they would'nt it. This results indicated that is need to do the nasal provocation test before the choice of antigens for the specific immunotherapy because the prick skin test was very often positive but patients don't have the symptoms. Precise composition of the vaccine improved the course in first season in 77.9 per cent, in second season in 87.5 per cent and in third season in 91.6 per cent.
Hofman
T
T
Centrum Alergologii w Poznaniu.
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000627:therapeutic use*; D001985:Bronchial Provocation Tests; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007167:Immunotherapy; D008875:Middle Aged; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000628:therapy*; D012882:Skin Tests; D014612:Vaccines; D014614:Vaccines, Synthetic / Q000627:therapeutic use*
D000485:Allergens; D014612:Vaccines; D014614:Vaccines, Synthetic; C099681:allergovit
Wyniki swoistej immunoterapii preparatem Allergovit chorych z alergia pyłkowa.